Applied_RadOnc's profile picture. ARO publishes peer-reviewed clinical review articles, research, and clinical cases for Radiation Oncology professionals online.

Applied Radiation Oncology

@Applied_RadOnc

ARO publishes peer-reviewed clinical review articles, research, and clinical cases for Radiation Oncology professionals online.

✨ In case you missed it! Here it is, the most popular article for the month of November! 1️⃣ zurl.co/UfsaL | Late Effects of Pelvic Radiation Therapy in the Female Patient: A Comprehensive Review Thank you for being part of the conversation. Your interaction helps…

Applied_RadOnc's tweet image. ✨ In case you missed it!

Here it is, the most popular article for the month of November!

1️⃣ zurl.co/UfsaL | Late Effects of Pelvic Radiation Therapy in the Female Patient: A Comprehensive Review
 
Thank you for being part of the conversation. Your interaction helps…

✨ In case you missed it! This week we’re highlighting the 5 most popular posts from November — the stories you read, shared, and engaged with the most. 2️⃣ zurl.co/pPxK8 | A Review of Online Adaptive Radiation Therapy Thank you for being part of the conversation.…

Applied_RadOnc's tweet image. ✨ In case you missed it!

This week we’re highlighting the 5 most popular posts from November  — the stories you read, shared, and engaged with the most.

2️⃣  zurl.co/pPxK8 | A Review of Online Adaptive Radiation Therapy
 
Thank you for being part of the conversation.…

🍁 Happy Thanksgiving from the Anderson Publishing Team! Today, we’re especially grateful for our readers, authors, partners, and colleagues who make our work meaningful. Thank you for your trust, your engagement, and your continued support.

Applied_RadOnc's tweet image. 🍁 Happy Thanksgiving from the Anderson Publishing Team!

Today, we’re especially grateful for our readers, authors, partners, and colleagues who make our work meaningful.

Thank you for your trust, your engagement, and your continued support.

✨ In case you missed it! This week we’re highlighting the 5 most popular posts from November — the stories you read, shared, and engaged with the most. 3️⃣ zurl.co/X3Uky | CB-CHOP: A simple acronym for evaluating a radiation treatment plan Thank you for being part…

Applied_RadOnc's tweet image. ✨ In case you missed it!

This week we’re highlighting the 5 most popular posts from November  — the stories you read, shared, and engaged with the most.

3️⃣ zurl.co/X3Uky  |  CB-CHOP: A simple acronym for evaluating a radiation treatment plan

Thank you for being part…

✨ In case you missed it! This week we’re highlighting the 5 most popular posts from November — the stories you read, shared, and engaged with the most. 4️⃣ zurl.co/bAh2y | CHHiP vs PROFIT for Localized Prostate Cancer: A Retrospective Dosimetric Comparison of Organs…

Applied_RadOnc's tweet image. ✨ In case you missed it!

This week we’re highlighting the 5 most popular posts from November  — the stories you read, shared, and engaged with the most.

4️⃣ zurl.co/bAh2y  | CHHiP vs PROFIT for Localized Prostate Cancer: A Retrospective Dosimetric Comparison of Organs…

Planning Target Volume Margin Assessment of Retroperitoneal Tumors Using Robotic SBRT With Spine Tracking Learn more 🔗 zurl.co/9x6KF #radonc #radonced #radiationoncology

Applied_RadOnc's tweet image. Planning Target Volume Margin Assessment of Retroperitoneal Tumors Using Robotic SBRT With Spine Tracking

Learn more 🔗  zurl.co/9x6KF 

#radonc #radonced #radiationoncology

✨ In case you missed it! This week we’re highlighting the 5 most popular posts from November — the stories you read, shared, and engaged with the most. 5️⃣ zurl.co/P0yNw | Localized Prostate Cancer Recurrence Thank you for being part of the conversation. Your…

Applied_RadOnc's tweet image. ✨ In case you missed it!

This week we’re highlighting the 5 most popular posts from November  — the stories you read, shared, and engaged with the most.

5️⃣ zurl.co/P0yNw  | Localized Prostate Cancer Recurrence

Thank you for being part of the conversation. Your…
Applied_RadOnc's tweet image. ✨ In case you missed it!

This week we’re highlighting the 5 most popular posts from November  — the stories you read, shared, and engaged with the most.

5️⃣ zurl.co/P0yNw  | Localized Prostate Cancer Recurrence

Thank you for being part of the conversation. Your…
Applied_RadOnc's tweet image. ✨ In case you missed it!

This week we’re highlighting the 5 most popular posts from November  — the stories you read, shared, and engaged with the most.

5️⃣ zurl.co/P0yNw  | Localized Prostate Cancer Recurrence

Thank you for being part of the conversation. Your…
Applied_RadOnc's tweet image. ✨ In case you missed it!

This week we’re highlighting the 5 most popular posts from November  — the stories you read, shared, and engaged with the most.

5️⃣ zurl.co/P0yNw  | Localized Prostate Cancer Recurrence

Thank you for being part of the conversation. Your…

Case Report: Nasopharyngeal stenosis following curative chemoradiation therapy for oropharyngeal cancer in a patient with active oral lichen Learn more: zurl.co/jqXiQ #radonc #radiationoncology #radonced #meded #casereport

Applied_RadOnc's tweet image. Case Report: Nasopharyngeal stenosis following curative chemoradiation therapy for oropharyngeal cancer in a patient with active oral lichen
 
Learn more: zurl.co/jqXiQ 

#radonc #radiationoncology #radonced #meded #casereport

Case Study: Robotic-Assisted Seminal Vesicle Excision vs Brachytherapy for Isolated Seminal Vesicle Recurrence: 2 Case Reports 🔗 zurl.co/Rv500 #radonc #radiationoncology #menshealth #casestudy #movember #prostatecancer

Applied_RadOnc's tweet image. Case Study: Robotic-Assisted Seminal Vesicle Excision vs Brachytherapy for Isolated Seminal Vesicle Recurrence: 2 Case Reports
 
🔗 zurl.co/Rv500 

#radonc #radiationoncology #menshealth #casestudy #movember #prostatecancer
Applied_RadOnc's tweet image. Case Study: Robotic-Assisted Seminal Vesicle Excision vs Brachytherapy for Isolated Seminal Vesicle Recurrence: 2 Case Reports
 
🔗 zurl.co/Rv500 

#radonc #radiationoncology #menshealth #casestudy #movember #prostatecancer
Applied_RadOnc's tweet image. Case Study: Robotic-Assisted Seminal Vesicle Excision vs Brachytherapy for Isolated Seminal Vesicle Recurrence: 2 Case Reports
 
🔗 zurl.co/Rv500 

#radonc #radiationoncology #menshealth #casestudy #movember #prostatecancer

Radiation oncology is particularly prone to challenges in receiving approval for recommended therapies owing to prior authorizations and peer-to peer-appeals. 🔗 zurl.co/OTumG #radonc #radiationoncology #radonced

Applied_RadOnc's tweet image. Radiation oncology is particularly prone to challenges in receiving approval for recommended therapies owing to prior authorizations and peer-to peer-appeals.  

🔗 zurl.co/OTumG  

#radonc #radiationoncology #radonced

Curious to hear more from Hasan Murshed, MD, MS, a radiation oncologist and medical director of the @HopeRadiationCC in Lynn Haven, Florida? Read his full interview in Issue 11 of the Rad Onc Student Scan! zurl.co/VjH00 #radonc #radiationoncology #radonced

Applied_RadOnc's tweet image. Curious to hear more from Hasan Murshed, MD, MS, a radiation oncologist and medical director of the @HopeRadiationCC  in Lynn Haven, Florida? 

Read his full interview in Issue 11 of the Rad Onc Student Scan! zurl.co/VjH00  

#radonc #radiationoncology #radonced

Need CME/CE credits before the end of the year? 🎓🔗 zurl.co/fyc2H These activities have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the…

Applied_RadOnc's tweet image. Need CME/CE credits before the end of the year?

🎓🔗 zurl.co/fyc2H 

These activities have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the…

Adenosquamous carcinoma (ADSC) is a rare and aggressive head and neck tumor that was first described in 1968. A rare cancer, only 16 cases of primary ADSC of the nasal cavity, excluding paranasal sinuses, have been reported. 🔗 zurl.co/OTumG #radonc #radonced

Applied_RadOnc's tweet image. Adenosquamous carcinoma (ADSC) is a rare and aggressive head and neck tumor that was first described in 1968. A rare cancer, only 16 cases of primary ADSC of the nasal cavity, excluding paranasal sinuses, have been reported.  

🔗 zurl.co/OTumG 

 #radonc #radonced…

Combination of External Beam Radiation Therapy and Immune Checkpoint Inhibitors in Cancer Treatment: Mechanisms, Limitations, and Clinical Applications 🔗 zurl.co/yOKX9 #radonc #radonced #radiationoncology

Applied_RadOnc's tweet image. Combination of External Beam Radiation Therapy and Immune Checkpoint Inhibitors in Cancer Treatment: Mechanisms, Limitations, and Clinical Applications

🔗 zurl.co/yOKX9 
 
#radonc #radonced #radiationoncology

The Use of Adaptive Radiation in a Retroperitoneal Seminoma Patient with Poor Candidacy for Chemotherapy: A Teaching Case 🔗 zurl.co/O5wa9 #radonc #radonced #menshealth #movember

Applied_RadOnc's tweet image. The Use of Adaptive Radiation in a Retroperitoneal Seminoma Patient with Poor Candidacy for Chemotherapy: A Teaching Case
 
🔗 zurl.co/O5wa9 

#radonc #radonced #menshealth #movember
Applied_RadOnc's tweet image. The Use of Adaptive Radiation in a Retroperitoneal Seminoma Patient with Poor Candidacy for Chemotherapy: A Teaching Case
 
🔗 zurl.co/O5wa9 

#radonc #radonced #menshealth #movember

Cancer treatment inequity is one of today’s most critical healthcare concerns. Although radiation therapy is a keystone therapy in developed countries, low- and middle-income countries (LMICs) face significant gaps in availability. 🔗 zurl.co/eA1Oi #radonc

Applied_RadOnc's tweet image. Cancer treatment inequity is one of today’s most critical healthcare concerns. Although radiation therapy is a keystone therapy in developed countries, low- and middle-income countries (LMICs) face significant gaps in availability.  

🔗 zurl.co/eA1Oi 

#radonc…

Curious to hear more from @Majed_Alghamdi_? Read his full interview in Issue 11 of the Rad Onc Student Scan! zurl.co/VjH00 #radonc #radiationoncology #radoncresident

Applied_RadOnc's tweet image. Curious to hear more from  @Majed_Alghamdi_? 

Read his full interview in Issue 11 of the Rad Onc Student Scan! zurl.co/VjH00 

#radonc #radiationoncology #radoncresident

Localized Prostate Cancer Recurrence 🔗 ow.ly/YRLU50Xp1ls A 70-year-old man presented with persistent rising prostate specific antigen (PSA) of 3.2ng/mL in July 2020... #Movember #MensHealth #ProstateCancer #RadOnc #RadOncEd

Applied_RadOnc's tweet image. Localized Prostate Cancer Recurrence

🔗 ow.ly/YRLU50Xp1ls

A 70-year-old man presented with persistent rising prostate specific antigen (PSA) of 3.2ng/mL in July 2020...

#Movember #MensHealth #ProstateCancer #RadOnc #RadOncEd

📢 All new Rad Onc Student Scan! 🔗 ow.ly/p99T50Xp1vk ✔️ Get industry insights ✔️ Read up on hot topics in rad onc ✔️ Check out the virtual rounds ✔️ Find career development opportunities #RadOnc #RadiationOncology #RadOncEd @AnthonyAlanis01 @LauraMaule3 @SylviaChoo5

Applied_RadOnc's tweet image. 📢 All new Rad Onc Student Scan!

🔗 ow.ly/p99T50Xp1vk

✔️ Get industry insights
✔️ Read up on hot topics in rad onc
✔️ Check out the virtual rounds
✔️ Find career development opportunities

#RadOnc #RadiationOncology #RadOncEd 
@AnthonyAlanis01 @LauraMaule3 @SylviaChoo5…

Curious to hear more from radiation oncologist Clifton D. Fuller, MD, PhD? 🔗 bit.ly/3EEiHpW #RadOnc #RadOncResident #RadOncResidency #Resident

Applied_RadOnc's tweet image. Curious to hear more from radiation oncologist Clifton D. Fuller, MD, PhD?  

🔗 bit.ly/3EEiHpW

#RadOnc #RadOncResident #RadOncResidency #Resident

Loading...

Something went wrong.


Something went wrong.